Chimeron Bio Enters Into Manufacturing Agreement With FUJIFILM Diosynth Biotechnologies to Advance i

PHILADELPHIA & COLLEGE STATION, Texas--(BUSINESS WIRE)--Chimeron Bio, an RNA company developing self-amplifying RNA (saRNA) vaccines and therapeutics designed on its proprietary ChaESAR™ RNA delivery platform, today announced it has entered into a manufacturing agreement with FUJIFILM Diosynth Biotechnologies (FDB),...

Related Keywords

United States ,Watertown ,Massachusetts ,Denmark ,North Carolina ,United Kingdom ,Thousand Oaks ,California ,Texas ,Research Triangle Park ,Philadelphia ,Pennsylvania ,Holly Springs ,Jolly Mazumdar ,Gerry Farrell ,Chimeron Bio ,Diosynth Biotechnologie ,Chimeron Cha ,Contract Development ,Fujifilm ,Mitsubishi Corporation ,Manufacturing Organization ,Company Oncology ,College Station ,Bulk Drug Substance ,Biotechnologie United Kingdom ,